PLCO: Evolution of an epidemiologic resource and opportunities for future studies

Reviews on Recent Clinical Trials

Volumn 10, Issue 3, 2015, Pages 238-245

  Black, Amanda ^a   Huang, Wen Yi ^a   Wright, Patrick ^b   Riley, Tom ^b   Mabie, Jerome ^b   Mathew, Sunitha ^c   Ragard, Lawrence ^c   Hermansen, Sigurd ^c   Yu, Kelly ^a   Pinsky, Paul ^a   Prorok, Philip C ^a   Freedman, Neal D ^a   Hoover, Robert N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c WESTAT   (United States)

Author keywords

Cancer research; Cohort; Epidemiologic resource; PLCO; Screening trial

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; DIETARY INTAKE; DRUG USE; EMPLOYMENT; FOLLOW UP; GENDER; HOUSING; HUMAN; INCOME; INFORMATION PROCESSING; LIFESTYLE; LIVER CANCER; LUNG CANCER; MEDICAL HISTORY; MEDICARE; NATIONAL HEALTH ORGANIZATION; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RACE; SMOKING; STUDY DESIGN; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; ECONOMICS; FEMALE; FINANCIAL MANAGEMENT; FORECASTING; LUNG NEOPLASMS; MALE; MASS SCREENING; MULTICENTER STUDY (TOPIC); NEOPLASMS; ORGANIZATION AND MANAGEMENT; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; EPIDEMIOLOGIC METHODS; FEMALE; FORECASTING; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MULTICENTER STUDIES AS TOPIC; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 84946071873     PISSN: 15748871     EISSN: 18761038     Source Type: Journal    
DOI: 10.2174/157488711003150928130654     Document Type: Article

References (10)

1. Zhu CS, Pinsky PF, Kramer BS, et al. The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. J Natl Cancer Inst 2013; 105(22): 1684-93.
2. Hayes RB, Reding D, Kopp W, et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Controlled Clin Trials 2000; 21(6 Suppl): 349S- 55S.
3. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clin Trials 2000; 21(6 Suppl): 273S-309S.
4. O'Brien B, Nichaman L, Browne JE, Levin DL, Prorok PC, Gohagan JK. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clin Trials 2000; 21(6 Suppl): 310S-28S.
5. Carrick DM, Black A, Gohagan J, et al. The PLCO Biorepository: Creating, maintaining, and administering a unique biospecimen resource. Rev Recent Clin Trials, Rev Rec Clin Trials, 2015; 10(4):
6. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406(6797): 747-52.
7. Schairer C, McCarty CA, Isaacs C, et al. Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort. Horm Cancer 2010; 1(2): 100-11.
8. Barrdahl M, Canzian F, Lindstrom S, et al. Association of breast cancer risk loci with breast cancer survival. Int J Cancer 2015; [Epub ahead of print].
9. Mondul AM, Shui IM, Yu K, et al. Vitamin D-associated genetic variation and risk of breast cancer in the Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2015; 24(3): 627-30.
10. Falk RT, Maas P, Schairer C, et al. Alcohol and risk of breast cancer in postmenopausal women: an analysis of etiological heterogeneity by multiple tumor characteristics. Am J Epidemiol 2014; 180(7): 705-17.